Patients with AD have higher plasma levels of cytokines, such as interleukin (IL)-6 and IL-1β [7], than healthy controls, while in patients with mild to moderate AD, elevation in serum tumor necrosis factor (TNF)-α is associated with cognitive decline [8]. This evidence concerns the gene IL6 and Alzheimer disease.